Sumitomo Mitsui Trust Holdings Inc. trimmed its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 1.9% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,056,726 shares of the healthcare conglomerate’s stock after selling 80,468 shares during the quarter. UnitedHealth Group comprises about 0.9% of Sumitomo Mitsui Trust Holdings Inc.’s holdings, making the stock its 15th largest position. Sumitomo Mitsui Trust Holdings Inc. owned 0.43% of UnitedHealth Group worth $989,882,000 at the end of the most recent quarter.
Other institutional investors have also bought and sold shares of the company. Eastern Bank grew its position in UnitedHealth Group by 2.0% during the second quarter. Eastern Bank now owns 69,088 shares of the healthcare conglomerate’s stock worth $16,858,000 after buying an additional 1,375 shares in the last quarter. Enterprise Bank & Trust Co purchased a new position in UnitedHealth Group during the first quarter worth about $3,785,000. Private Advisors LLC grew its position in UnitedHealth Group by 57.9% during the first quarter. Private Advisors LLC now owns 6,501 shares of the healthcare conglomerate’s stock worth $1,607,000 after buying an additional 2,385 shares in the last quarter. First City Capital Management Inc. purchased a new position in UnitedHealth Group during the fourth quarter worth about $580,000. Finally, Capital Investment Advisors LLC grew its position in UnitedHealth Group by 26.2% during the second quarter. Capital Investment Advisors LLC now owns 6,379 shares of the healthcare conglomerate’s stock worth $1,556,000 after buying an additional 1,323 shares in the last quarter. Institutional investors and hedge funds own 85.87% of the company’s stock.
In other news, Director William C. Ballard, Jr. sold 12,000 shares of the business’s stock in a transaction dated Tuesday, July 23rd. The stock was sold at an average price of $255.31, for a total value of $3,063,720.00. Following the completion of the sale, the director now owns 61,309 shares of the company’s stock, valued at approximately $15,652,800.79. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Richard T. Burke sold 10,000 shares of the business’s stock in a transaction dated Tuesday, June 11th. The shares were sold at an average price of $248.00, for a total value of $2,480,000.00. Following the completion of the sale, the director now directly owns 187,663 shares of the company’s stock, valued at approximately $46,540,424. The disclosure for this sale can be found here. In the last three months, insiders sold 32,000 shares of company stock valued at $7,963,620. 0.82% of the stock is currently owned by corporate insiders.
UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share for the quarter, beating analysts’ consensus estimates of $3.46 by $0.14. UnitedHealth Group had a return on equity of 25.20% and a net margin of 5.51%. The company had revenue of $60.60 billion during the quarter, compared to analyst estimates of $60.59 billion. During the same quarter in the previous year, the company posted $3.14 EPS. UnitedHealth Group’s revenue for the quarter was up 8.0% on a year-over-year basis. As a group, research analysts predict that UnitedHealth Group Inc will post 14.82 earnings per share for the current fiscal year.
UNH has been the subject of several research analyst reports. Barclays dropped their price target on UnitedHealth Group from $290.00 to $270.00 and set an “overweight” rating for the company in a research note on Wednesday, April 17th. Citigroup raised UnitedHealth Group from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $247.00 to $280.00 in a research note on Friday, May 10th. UBS Group initiated coverage on UnitedHealth Group in a research note on Tuesday, April 23rd. They set a “neutral” rating and a $238.00 price target for the company. Zacks Investment Research raised UnitedHealth Group from a “sell” rating to a “buy” rating and set a $269.00 price target for the company in a research note on Monday, July 22nd. Finally, Raymond James lifted their price target on UnitedHealth Group from $265.00 to $300.00 and gave the stock a “buy” rating in a research note on Friday, July 19th. One analyst has rated the stock with a sell rating, one has given a hold rating and eighteen have issued a buy rating to the company’s stock. UnitedHealth Group has a consensus rating of “Buy” and an average target price of $295.06.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Story: What economic reports are most valuable to investors?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.